| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |